Seeking Life Science Innovation Opportunities and Beyond: The Art of Blending Science, Medicine, and Business

Main Article Content

Arthur A. Boni, PhD John M. York Natasha Boyette Dabin Im

Abstract

This update on life science innovation extends Boni's 2018 works 1,2 to include industry stakeholder expert opinion. The first section summarizes current industry challenges, successes, and best practices that support sustained and disruptive innovation in the biopharma industry. It charts a brief overview of proven models for innovation, entrepreneurial thinking, and for development of open innovation as applied to this complex, challenging, continuously evolving industry. This initial discussion advocates the pursuit of commercialization that 1) incorporates a phased, interdisciplinary, collaborative approach and 2) blends the principles of business, science, and technology through diverse, collaborative teams, networks, and alliances. The paper transitions to a second section. This effort builds on these concepts and provides insights and alternative perspectives from a cohort of leading experts within the biomedical investment, development, and commercialization space. It also illustrates and leverages collective intelligence through interdisciplinary perspectives across the life science landscape and reinforces trends for pursuing innovation.

Article Details

How to Cite
BONI, Arthur A. et al. Seeking Life Science Innovation Opportunities and Beyond: The Art of Blending Science, Medicine, and Business. Medical Research Archives, [S.l.], v. 11, n. 2, feb. 2023. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/3443>. Date accessed: 21 mar. 2023. doi: https://doi.org/10.18103/mra.v11i2.3443.
Section
Research Articles